Literature DB >> 28174184

Multiple myeloma presenting with bilateral ankle pain (microangiopathy) and complicated by streptococcal meningitis and Pneumocystis carinii pneumonia.

Louise Dunphy1, Neeraj Singh1, Elizabeth Keating2.   

Abstract

Multiple myeloma is characterised by the neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin. This clone of plasma cells proliferates in the bone marrow, resulting in extensive skeletal destruction with osteolytic lesions, osteopenia and pathological fractures. Additional disease-related complications include hypercalcaemia, renal insufficiency, anaemia and infection. We present the case of a 64-year-old woman presenting with rapid onset, painful distal symmetrical lower limb weakness and an acute kidney injury. Owing to her IgG κ paraprotein (kappa light chain 4620, kappa:lambda ratio 826), she was diagnosed with probable plasma cell myeloma. This diagnosis was confirmed following a trephine biopsy. She required renal replacement therapy, inotropic support and a percutaneous tracheostomy. She became acutely confused with a Glasgow Coma Scale score of 10/15 and a CT head showed no acute pathology. Further investigation with a lumbar puncture confirmed the diagnosis of streptococcal meningitis. She was treated with intravenous acyclovir, ceftriaxone and fluconazole. Her non-bronchoalveolar lavage revealed a diagnosis of Pneumocystis carinii pneumonia and she required treatment with co-trimoxazole. This case report discusses the clinical presentation, diagnostic algorithm and treatment of myeloma. This manuscript offers an important clinical reminder to consider myeloma in the differential diagnosis in patients presenting with bone pain and acute kidney injury. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28174184      PMCID: PMC5307268          DOI: 10.1136/bcr-2016-217289

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trials.

Authors:  Minjie Gao; Guang Yang; Ying Han; Yuanyuan Kong; Huiqun Wu; Yi Tao; Fenghuang Zhan; Jumei Shi; Xiaosong Wu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

3.  Guidelines on the diagnosis and management of multiple myeloma 2005.

Authors:  Alastair Smith; Finn Wisloff; Diana Samson
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

4.  Remarks on the pathology of mollities ossium; with cases.

Authors:  S Solly
Journal:  Med Chir Trans       Date:  1844

Review 5.  Chemotherapy with or without plasmapheresis in acute renal failure due to multiple myeloma: a meta-analysis.

Authors:  Xiaoyong Yu; Liangying Gan; Zhaohui Wang; Bao Dong; Xiaohong Chen
Journal:  Int J Clin Pharmacol Ther       Date:  2015-05       Impact factor: 1.366

6.  Prognostic value and efficacy evaluation of novel drugs for cytogenetic aberrations in multiple myeloma: a meta-analysis.

Authors:  Wenjun Yu; Jianyong Li; Lijuan Chen
Journal:  Int J Clin Exp Med       Date:  2014-11-15

7.  A meta-analysis of the antitumor effect and safety of bisphosphonates in the treatment of multiple myeloma.

Authors:  Xiaoxue Wang; Xiaojing Yan; Yan Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.

Authors:  Kathrin Kuhr; Daniel Wirth; Kunal Srivastava; Walter Lehmacher; Martin Hellmich
Journal:  Eur J Clin Pharmacol       Date:  2015-12-16       Impact factor: 2.953

Review 9.  Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.

Authors:  Yucai Wang; Fang Yang; Yan Shen; Wenwen Zhang; Jacqueline Wang; Victor T Chang; Borje S Andersson; Muzaffar H Qazilbash; Richard E Champlin; James R Berenson; Xiaoxiang Guan; Michael L Wang
Journal:  J Natl Cancer Inst       Date:  2015-11-18       Impact factor: 13.506

10.  Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials.

Authors:  Chun-Jing Geng; Qian Liang; Jian-Hong Zhong; Min Zhu; Fan-Ying Meng; Ning Wu; Rui Liang; Bin-Yi Yuan
Journal:  BMJ Open       Date:  2015-06-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.